<?xml version="1.0" encoding="UTF-8"?>
<p>For the NIFTY study, the vaccine manufactured by the Institut Pasteur de Dakar will be used. Adult participants (n=480) will be randomized for vaccination with full standard dose or with 1000, 500 or 250 IU (i.e. 4 arms) with a 1:1:1:1 allocation ratio. Results for the safety and primary outcome of the adult study will then be reviewed by the DSMB, and the lowest non-inferior dose in the adult study selected for assessment in children aged 9 months &lt; 5 years (n=420) in comparison to full standard dose (i.e. two arms) with a 1:1 allocation ratio.</p>
